Discontinuation syndrome is a set of physical and psychological symptoms that can occur when you stop taking certain medications, most commonly antidepressants. It affects roughly 43% of people who stop antidepressants, based on pooled data from multiple studies. Symptoms typically begin within two to four days of stopping or sharply reducing the dose and usually last one to two weeks, though they occasionally persist much longer.
What Causes It
When you take an antidepressant for weeks or months, your brain adjusts to the consistent presence of the drug. Serotonin-based antidepressants, for example, keep more serotonin available in your brain than your body would produce on its own. Your brain compensates by dialing down its sensitivity to serotonin. When the medication is suddenly removed, serotonin levels drop faster than your brain can readjust.
The process isn’t limited to serotonin alone. At least two other chemical signaling systems in the brain, one involving norepinephrine (which regulates alertness and stress responses) and another involving acetylcholine (which plays a role in memory and muscle control), also get disrupted. This is why the symptoms are so varied: they span everything from flu-like body aches to electrical sensations in your head.
Which Medications Carry the Highest Risk
Not all antidepressants are equally likely to cause discontinuation symptoms. The biggest factor is how quickly the drug leaves your body. Medications with short half-lives (meaning they’re cleared from your bloodstream in hours rather than days) leave a sharper gap for your brain to cope with.
A 2024 systematic review and meta-analysis in The Lancet Psychiatry identified the medications most frequently and severely linked to discontinuation symptoms. Venlafaxine, desvenlafaxine, and paroxetine consistently ranked among the worst offenders for symptom severity. Imipramine, an older tricyclic antidepressant, also showed high severity rates. Escitalopram was associated with a higher frequency of symptoms, though not always the most severe ones. By contrast, fluoxetine (Prozac), which has a very long half-life, is one of the least likely to cause problems because it leaves your system gradually on its own.
What the Symptoms Feel Like
Clinicians use the mnemonic FINISH to capture the six main categories of discontinuation symptoms:
- Flu-like symptoms: fatigue, muscle aches, chills, sweating
- Insomnia: trouble falling or staying asleep, vivid or disturbing dreams
- Nausea: stomach upset, sometimes vomiting or diarrhea
- Imbalance: dizziness, lightheadedness, vertigo
- Sensory disturbances: tingling, numbness, and “brain zaps”
- Hyperarousal: anxiety, agitation, irritability
Brain zaps deserve special attention because they’re one of the most distinctive and distressing symptoms. People describe them as brief, sudden electrical shock sensations in the head that can radiate outward. Research published in 2019 found that brain zaps are most commonly triggered by abrupt discontinuation, and they have an unexpected association with lateral eye movements, meaning they often fire when you look to the side. Even gradual tapering only partially reduces them. They remain poorly understood, and no reliable treatment exists beyond restarting the medication or waiting them out.
How to Tell It Apart From Relapse
One of the trickiest aspects of discontinuation syndrome is that some of its psychological symptoms, particularly anxiety, low mood, and irritability, overlap with the condition the antidepressant was treating in the first place. This raises an obvious and stressful question: are you experiencing withdrawal, or is your depression coming back?
Three features help distinguish the two. First, timing: discontinuation symptoms show up within days of a dose change, while a genuine relapse of depression tends to develop over weeks or months. Second, the mix of symptoms: discontinuation syndrome almost always includes physical symptoms alongside the psychological ones. If you have dizziness, brain zaps, or flu-like feelings at the same time as low mood, that points toward withdrawal rather than relapse. Third, the pattern: withdrawal symptoms tend to follow a “wave” pattern, peaking and then gradually fading. And if you restart the medication, discontinuation symptoms typically resolve within a day or two, much faster than a relapse would respond to treatment.
Not Just Antidepressants
Although the term “discontinuation syndrome” is most commonly associated with antidepressants, similar withdrawal reactions occur with other psychiatric medications, particularly benzodiazepines (drugs like lorazepam and diazepam, prescribed for anxiety and insomnia). Research comparing the two classes has found that 37 of 42 identified withdrawal symptoms were very similar between benzodiazepines and SSRIs. The time courses of withdrawal are also comparable.
Where they differ is in the bigger picture. Benzodiazepine withdrawal can include perceptual hypersensitivities, where sounds, light, or touch become painfully amplified, and these can be protracted, lasting months. Benzodiazepine withdrawal is also generally considered more medically serious, with a less favorable risk-to-benefit balance overall.
How Tapering Reduces the Risk
Gradually reducing your dose before stopping, rather than quitting abruptly, is the primary strategy for minimizing discontinuation symptoms. But the data on tapering is more nuanced than “go slow.” One meta-analysis found that tapering reduced the incidence of withdrawal symptoms compared with abrupt stoppage (34.5% versus 42.5%), but the difference wasn’t statistically significant. This suggests that how you taper matters as much as whether you taper.
The approach gaining the most clinical traction is called hyperbolic tapering. The idea is straightforward: instead of cutting your dose by the same amount each step (say, dropping from 20mg to 15mg to 10mg to 5mg to zero), you make each reduction smaller than the last. The reason is that the relationship between dose and effect on the brain isn’t linear. Going from 10mg to 5mg doesn’t halve the drug’s effect on your brain receptors; it might reduce it by 80%. So the final reductions need to be tiny to avoid a cliff-edge drop in brain activity.
In practice, hyperbolic tapering involves daily reductions averaging about 4.5% of the previous day’s dose, or roughly 25% per week. Research comparing this approach with larger weekly step-downs (about 33% per step) found that the larger steps produced more withdrawal symptoms. The UK’s National Institute for Health and Care Excellence (NICE) and several specialty organizations now recommend hyperbolic dose reductions as the standard approach. One practical challenge is that standard pill sizes don’t come in the tiny doses needed for the final stages of a taper, sometimes requiring liquid formulations or pill-splitting techniques.
Why the Terminology Matters
You’ll see this condition referred to as both “discontinuation syndrome” and “antidepressant withdrawal syndrome.” The distinction isn’t just academic. The term “discontinuation syndrome” was introduced in part to differentiate these symptoms from the withdrawal associated with addictive substances like opioids or alcohol. Antidepressants are not addictive in the traditional sense: people don’t develop cravings, seek escalating doses, or engage in compulsive drug-seeking behavior.
However, some clinicians and patient advocates argue that “discontinuation syndrome” understates the severity of the experience, and that the word “withdrawal” more accurately conveys what people go through. A 2025 update in the Therapeutics Letter noted that the term “protracted withdrawal” can also be misleading, because it implies that simply restarting the drug will always resolve the problem, which isn’t guaranteed in longer-lasting cases. Whatever you call it, the physiological reality is the same: your brain adapted to the drug, and removing it too quickly causes real, measurable symptoms.